Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancerMissak Haigentz, Robert I. Haddad, Catherine Sarta et al.|Oral Oncology|2012Cited by 91
Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer CellsLars Tögel, John M. Mariadason|Molecular Cancer Therapeutics|2016Cited by 89
Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug TargetsJohn M. Mariadason|iScience|2019Cited by 22
DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesisLars Tögel, John M. Mariadason|Scientific Reports|2018Cited by 19